Anti-complement Strategies in Experimental Sepsis

Author： Ward Peter A. Riedemann Niels C. Guo Ren-feng Huber-lang Markus Sarma J. Vidya Zetoune Firas S.

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.35, Iss.9, 2003-09, pp. : 601-603

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Carboxypeptidase B2 deficiency reveals opposite effects of complement C3a and C5a in a murine polymicrobial sepsis model

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 6, 2015-06 ,pp. : 1090-1102

John Wiley & Sons Inc

Access to resources Recommend Favorite

A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation

By Ogundele M. O.

Mediators of Inflammation, Vol. 7, Iss. 5, 1998-10 ,pp. : 363-365

Informa Healthcare

Access to resources Recommend Favorite

Serum complement levels in anti‐N‐methyl‐d‐aspartate receptor encephalitis

EUROPEAN JOURNAL OF NEUROLOGY, Vol. 25, Iss. 1, 2018-01 ,pp. : 178-184

John Wiley & Sons Inc

Access to resources Recommend Favorite

Strategies developed by bacteria and virus for protection from the human complement system

By Blom A. M.

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 64, Iss. 5, 2004-10 ,pp. : 479-496

Informa Healthcare

Access to resources Recommend Favorite

AT III/Sepsis: Die anti-inflammatorischen Wirkungen von Antithrombin III bei Sepsis

By Hoffmann J. Bernhardt W.

Intensivmedizin und Notfallmedizin, Vol. 41, Iss. 5, 2004-06 ,pp. : 315-321

Springer Publishing Company

Access to resources Recommend Favorite